Discover why Structure Therapeutics Inc. is rated Strong Buy after positive Aleniglipron phase 2b obesity data. Click for ...

The expansion of data centers to power the AI boom has more people wondering: what exactly is in a data center?

Talent without process is like a baseball team where the pitcher cooks fries for the concession stands and the shortstop is ...

Structure's aleniglipron elicited over 11% weight loss in a Phase II trial, sending the biotech's stock up nearly 103% as ...

A significant part of the answer lies in the company’s transformation. Snowflake is no longer merely presenting itself as a ...

The filament of matter stretches 50 million light-years, and contains a row of galaxies 5.5 million light-years long that are ...

You can prompt an AI model with a line of text, and it will generate most of the code needed to build an app, tool or website ...

"What we have seen from ... the second Trump administration is a strong focus on centralization and consolidation of common services," said John Marshall.

A peer-reviewed paper about Chinese startup DeepSeek's models explains their training approach but not how they work through ...

As our use of online tools expands wildly with the advent of artificial intelligence, so does the demand for data.

Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on obesity, today ...

AS artificial intelligence (AI) continues to transform industries and economies, Southeast Asia is emerging as a critical test case for balancing AI growth, sustainability, and sovereignty. According ...